Cargando…

Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age

The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts. This recently FDA-cleared system consists of the insulin pump...

Descripción completa

Detalles Bibliográficos
Autores principales: Ly, Trang T., Layne, Jennifer E., Huyett, Lauren M., Nazzaro, David, O’Connor, Jason B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313290/
https://www.ncbi.nlm.nih.gov/pubmed/30239214
http://dx.doi.org/10.1177/1932296818798836
_version_ 1783383899543437312
author Ly, Trang T.
Layne, Jennifer E.
Huyett, Lauren M.
Nazzaro, David
O’Connor, Jason B.
author_facet Ly, Trang T.
Layne, Jennifer E.
Huyett, Lauren M.
Nazzaro, David
O’Connor, Jason B.
author_sort Ly, Trang T.
collection PubMed
description The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts. This recently FDA-cleared system consists of the insulin pump (“Pod”), which is worn on body and delivers insulin, and the Personal Diabetes Manager (PDM), which is a handheld device used to wirelessly control and monitor the Pod functionality. The PDM can also be paired with the CONTOUR(®) NEXT ONE blood glucose (BG) meter (Ascensia Diabetes Care, Basel, Switzerland) to wirelessly receive BG readings. This review provides a detailed description of the Pod and PDM. Key features of the Pod are described, including the novel pump delivery mechanism, waterproof (IP28) housing design, and automated cannula insertion. The technology introduced in the new system, such as touchscreen PDM interface, Bluetooth(®) wireless technology, and wireless internet connectivity, is also presented. Last, Omnipod(®) Insulin Management System clinical data are reviewed, including early feasibility results for the Omnipod Horizon™ Automated Glucose Control hybrid closed-loop system.
format Online
Article
Text
id pubmed-6313290
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-63132902019-09-21 Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age Ly, Trang T. Layne, Jennifer E. Huyett, Lauren M. Nazzaro, David O’Connor, Jason B. J Diabetes Sci Technol Special Section: Insulin Patch Pumps and Novel Insulin Delivery Systems The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts. This recently FDA-cleared system consists of the insulin pump (“Pod”), which is worn on body and delivers insulin, and the Personal Diabetes Manager (PDM), which is a handheld device used to wirelessly control and monitor the Pod functionality. The PDM can also be paired with the CONTOUR(®) NEXT ONE blood glucose (BG) meter (Ascensia Diabetes Care, Basel, Switzerland) to wirelessly receive BG readings. This review provides a detailed description of the Pod and PDM. Key features of the Pod are described, including the novel pump delivery mechanism, waterproof (IP28) housing design, and automated cannula insertion. The technology introduced in the new system, such as touchscreen PDM interface, Bluetooth(®) wireless technology, and wireless internet connectivity, is also presented. Last, Omnipod(®) Insulin Management System clinical data are reviewed, including early feasibility results for the Omnipod Horizon™ Automated Glucose Control hybrid closed-loop system. SAGE Publications 2018-09-21 /pmc/articles/PMC6313290/ /pubmed/30239214 http://dx.doi.org/10.1177/1932296818798836 Text en © 2018 Diabetes Technology Society http://creativecommons.org/licenses/by/4.0/ This article is distributed under the terms of the Creative Commons Attribution 4.0 License (http://www.creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Special Section: Insulin Patch Pumps and Novel Insulin Delivery Systems
Ly, Trang T.
Layne, Jennifer E.
Huyett, Lauren M.
Nazzaro, David
O’Connor, Jason B.
Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
title Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
title_full Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
title_fullStr Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
title_full_unstemmed Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
title_short Novel Bluetooth-Enabled Tubeless Insulin Pump: Innovating Pump Therapy for Patients in the Digital Age
title_sort novel bluetooth-enabled tubeless insulin pump: innovating pump therapy for patients in the digital age
topic Special Section: Insulin Patch Pumps and Novel Insulin Delivery Systems
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6313290/
https://www.ncbi.nlm.nih.gov/pubmed/30239214
http://dx.doi.org/10.1177/1932296818798836
work_keys_str_mv AT lytrangt novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage
AT laynejennifere novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage
AT huyettlaurenm novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage
AT nazzarodavid novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage
AT oconnorjasonb novelbluetoothenabledtubelessinsulinpumpinnovatingpumptherapyforpatientsinthedigitalage